239 related articles for article (PubMed ID: 27533020)
21. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
Feng L; Xie Y; Zhang H; Wu Y
Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
[TBL] [Abstract][Full Text] [Related]
22. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway.
He X; Liu Z; Peng Y; Yu C
Biochem Biophys Res Commun; 2016 Jan; 469(4):1041-8. PubMed ID: 26682928
[TBL] [Abstract][Full Text] [Related]
24. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
25. NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production.
Oh SS; Kim D; Kim DH; Chang HH; Sohn KC; Kim KH; Jung SH; Lee BK; Kim JH; Kim KD
Carcinogenesis; 2012 Oct; 33(10):1882-8. PubMed ID: 22696597
[TBL] [Abstract][Full Text] [Related]
26. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
Zhang JF; He ML; Fu WM; Wang H; Chen LZ; Zhu X; Chen Y; Xie D; Lai P; Chen G; Lu G; Lin MC; Kung HF
Hepatology; 2011 Dec; 54(6):2137-48. PubMed ID: 21809363
[TBL] [Abstract][Full Text] [Related]
27. MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.
Li Y; Wang H; Li J; Yue W
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):48-55. PubMed ID: 24345480
[TBL] [Abstract][Full Text] [Related]
28. miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.
Ehrlich L; Hall C; Venter J; Dostal D; Bernuzzi F; Invernizzi P; Meng F; Trzeciakowski JP; Zhou T; Standeford H; Alpini G; Lairmore TC; Glaser S
Am J Pathol; 2017 Mar; 187(3):570-580. PubMed ID: 28087162
[TBL] [Abstract][Full Text] [Related]
29. Association of microRNA-181c expression with the progression and prognosis of human gastric carcinoma.
Cui M; Yue L; Fu Y; Yu W; Hou X; Zhang X
Hepatogastroenterology; 2013; 60(125):961-4. PubMed ID: 23425811
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.
Mansini AP; Lorenzo Pisarello MJ; Thelen KM; Cruz-Reyes M; Peixoto E; Jin S; Howard BN; Trussoni CE; Gajdos GB; LaRusso NF; Perugorria MJ; Banales JM; Gradilone SA
Hepatology; 2018 Aug; 68(2):561-573. PubMed ID: 29406621
[TBL] [Abstract][Full Text] [Related]
31. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
Olaizola P; Lee-Law PY; Fernandez-Barrena MG; Alvarez L; Cadamuro M; Azkargorta M; O'Rourke CJ; Caballero-Camino FJ; Olaizola I; Macias RIR; Marin JJG; Serrano-Maciá M; Martinez-Chantar ML; Avila MA; Aspichueta P; Calvisi DF; Evert M; Fabris L; Castro RE; Elortza F; Andersen JB; Bujanda L; Rodrigues PM; Perugorria MJ; Banales JM
J Hepatol; 2022 Jul; 77(1):177-190. PubMed ID: 35217064
[TBL] [Abstract][Full Text] [Related]
32. Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma.
Han S; Wang D; Tang G; Yang X; Jiao C; Yang R; Zhang Y; Huo L; Shao Z; Lu Z; Zhang J; Li X
Oncotarget; 2017 Aug; 8(34):56635-56650. PubMed ID: 28915618
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
34. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.
Yue X; Zhao Y; Zhang C; Li J; Liu Z; Liu J; Hu W
Oncotarget; 2016 Jan; 7(4):3777-90. PubMed ID: 26716902
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C Virus Mediated Inhibition of miR-181c Activates ATM Signaling and Promotes Hepatocyte Growth.
Patra T; Meyer K; Ray RB; Ray R
Hepatology; 2020 Mar; 71(3):780-793. PubMed ID: 31400158
[TBL] [Abstract][Full Text] [Related]
36. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
[TBL] [Abstract][Full Text] [Related]
37. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.
Hu W; Fan C; Jiang P; Ma Z; Yan X; Di S; Jiang S; Li T; Cheng Y; Yang Y
Oncotarget; 2016 Jan; 7(1):209-23. PubMed ID: 26506239
[TBL] [Abstract][Full Text] [Related]
38. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract][Full Text] [Related]
39. Galangin Inhibits Cholangiocarcinoma Cell Growth and Metastasis through Downregulation of MicroRNA-21 Expression.
Zou Y; Li R; Kuang D; Zuo M; Li W; Tong W; Jiang L; Zhou M; Chen Y; Gong W; Liu L; Tou F
Biomed Res Int; 2020; 2020():5846938. PubMed ID: 32626749
[TBL] [Abstract][Full Text] [Related]
40. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells.
Silakit R; Kitirat Y; Thongchot S; Loilome W; Techasen A; Ungarreevittaya P; Khuntikeo N; Yongvanit P; Yang JH; Kim NH; Yook JI; Namwat N
PLoS One; 2018; 13(6):e0199827. PubMed ID: 29953500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]